NCT04662996View on ClinicalTrials.gov

Search for Predictive Factors of Resistance to Treatment for Metastatic Castration-resistant Prostate Cancer by Studying the Expression of microRNAs

NAActive, not recruitingINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

June 23, 2021

Primary Completion Date

November 30, 2023

Study Completion Date

November 30, 2023

Conditions
Prostate CancerResistance, DiseaseMicroRNAs
Interventions
BIOLOGICAL

Blood sample

one blood sample is done before beginning a first treatment line for a metastatic castration resistant prostate cancer

Trial Locations (1)

37044

University Hospital of Tours, Tours

All Listed Sponsors
lead

University Hospital, Tours

OTHER